ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Amberen Perimenopause Proprietary Compound

Also known as: Amberen SBDS, succinate-based dietary supplement, Amberen Perimenopause Proprietary Compound

Overview

Amberen Perimenopause Proprietary Compound is a non-hormonal dietary supplement designed to alleviate mild to moderate menopausal symptoms. It is a succinate-based blend containing succinic acid, amino acids, minerals, and vitamin E. Marketed as an alternative to hormone replacement therapy (HRT), it aims to reduce symptoms such as hot flashes, anxiety, sleep disturbances, and mood swings. While its ingredients are naturally occurring, the specific proprietary blend is unique. Research on Amberen is emerging, primarily from manufacturer-sponsored studies, indicating moderate to low quality of evidence due to potential conflicts of interest and a lack of extensive independent validation.

Benefits

Amberen has shown benefits in reducing mild to moderate menopausal symptoms. A pooled analysis of two randomized, placebo-controlled trials (n=250) reported significant reductions in hot flashes, anxiety, and sleep disturbances after 90 days of use compared to placebo. These improvements were noted in both physical and psychological symptoms. While human data on hormonal markers are limited, animal models suggested some normalization of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The supplement is primarily beneficial for women aged 42-60 experiencing mild to moderate menopausal symptoms. The clinical significance is supported by statistically significant symptom reductions (p<0.05) in the trials, with effects sustained up to 120 days. Secondary effects like improvements in weight and calcium metabolism were observed in murine models, but human data are currently lacking.

How it works

The mechanism of action for Amberen Perimenopause Proprietary Compound is not fully elucidated but is proposed to involve multiple pathways. The succinate component may influence mitochondrial energy metabolism and central nervous system function, potentially contributing to symptom relief. The amino acids and minerals included in the blend are thought to support neurotransmitter synthesis and help maintain hormonal balance. The supplement is believed to modulate the hypothalamic-pituitary-ovarian axis through non-hormonal pathways, thereby reducing menopausal symptoms. No direct estrogenic or hormonal receptor activity has been reported. The ingredients are common dietary compounds, suggesting generally good bioavailability, though detailed pharmacokinetic data for the proprietary blend are unavailable.

Side effects

Amberen Perimenopause Proprietary Compound has been generally well tolerated in clinical trials, with no serious adverse events reported. Specific common, uncommon, or rare side effects were not clearly detailed in the available research, indicating a low incidence of adverse reactions in the studied populations. There are no documented drug interactions, but caution is advised when used concurrently with hormone therapies or other supplements due to a lack of specific interaction studies. Contraindications are not well defined, but it is likely prudent to avoid use in hormone-sensitive conditions until more comprehensive data are available. Safety data are limited for special populations, including pregnant or breastfeeding women, and those with severe menopausal symptoms.

Dosage

Based on clinical trials, the recommended dosage for Amberen Perimenopause Proprietary Compound involves daily administration of the proprietary formula for a duration of 90 days. The exact dosage per individual ingredient within the blend is proprietary and not publicly detailed. Optimal and maximum safe dosages beyond the studied formulation have not been established. Benefits were observed after approximately three months of consistent daily use. The supplement is administered in an oral capsule form, as used in the clinical trials. No specific absorption factors or required cofactors have been reported, suggesting general dietary absorption of its components.

FAQs

Is Amberen effective for severe menopausal symptoms?

Evidence primarily supports relief for mild to moderate menopausal symptoms. For severe symptoms, hormone replacement therapy (HRT) or other medical treatments may be more appropriate.

Is Amberen safe for long-term use?

Long-term safety data are currently lacking. Existing evidence supports short-term use (up to 3 months) without serious adverse effects, but more research is needed for extended periods.

Can Amberen replace hormone therapy?

Amberen is a non-hormonal alternative, but it is generally considered less effective than HRT for managing severe menopausal symptoms. It may be suitable for those seeking non-hormonal options for mild to moderate symptoms.

When should I expect to see benefits from Amberen?

Clinical trials indicate that benefits, such as reductions in hot flashes and anxiety, are typically observed after approximately 90 days of consistent daily use.

Does Amberen affect hormone levels?

While some normalization of FSH and LH was observed in animal studies, the effects on human hormone levels are not clearly established in the available research.

Research Sources

  • https://pmc.ncbi.nlm.nih.gov/articles/PMC6875258/ – This pooled analysis of two identical randomized, placebo-controlled trials (n=250) investigated Amberen's efficacy and safety in peri- and postmenopausal women. The study found that Amberen significantly reduced mild to moderate menopausal symptoms, including hot flashes, anxiety, and sleep disturbances, compared to placebo over 90 days, and was well tolerated. However, the study was manufacturer-funded, indicating a potential for bias.
  • https://pubmed.ncbi.nlm.nih.gov/38189863/ – This systematic review and meta-analysis evaluated the efficacy of various plant-based supplements for menopausal symptoms. It concluded that plant-based supplements generally improve menopausal symptoms. However, it did not include specific data on Amberen, making its relevance indirect for Amberen's specific efficacy, though it supports the broader category of natural remedies.
  • https://experts.llu.edu/en/publications/extracted-or-synthesized-soybean-isoflavones-reduce-menopausal-ho-2 – This systematic review and meta-analysis focused on soy isoflavones and their effect on menopausal hot flashes. It found that soy isoflavones can reduce the frequency and severity of hot flashes. While not directly about Amberen, it provides context on other natural compounds used for menopausal symptom relief, highlighting the potential for non-hormonal interventions.

Recommended Articles

Best Supplements for Perimenopause Relief

Best Supplements for Perimenopause Relief

Certain supplements can alleviate perimenopausal symptoms, with consultation recommended for safety.